Taurine ameliorate alloxan induced oxidative stress and intrinsic apoptotic pathway in the hepatic tissue of diabetic rats

Food and Chemical Toxicology

Volumn 51, Issue 1, 2013, Pages 317-329

  Rashid, Kahkashan ^a   Das, Joydeep ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Alloxan; Diabetes; Liver dysfunction; Mitochondrial dependent apoptosis; Oxidative stress; Taurine

Indexed keywords

ALLOXAN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9; CATALASE; CYTOCHROME C; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEXOKINASE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TAURINE;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CENTRAL VEIN; CONTROLLED STUDY; CYTOSOL; DIABETES MELLITUS; DNA FRAGMENTATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME RELEASE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIVER CELL; LIVER DYSFUNCTION; LIVER INJURY; LIVER MITOCHONDRION; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; WEIGHT REDUCTION;

ALLOXAN; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; CASPASE 3; CASPASE 9; CYTOCHROMES C; DIABETES MELLITUS, EXPERIMENTAL; ENZYMES; GLUCOSE TRANSPORTER TYPE 2; LIPID PEROXIDATION; LIVER; MALE; MITOCHONDRIA; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TAURINE;

RATTUS;

EID: 84868554036     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.10.007     Document Type: Article

References (95)

1. Aerts L., Van Assche F.A. Taurine and taurine-deficiency in the perinatal period. J. Perinat. Med. 2002, 30:281-286.
2. Alvarado-Vasquez N., Zamudio P., Ceron E., Vanda B., Zenteno E., Carvajal-Sandoval G. Effect of glycine in streptozotocin induced diabetic rats. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2003, 134:521-527.
3. Baynes J.W. Role of oxidative stress in development of complication of diabetes. Diabetes 1991, 40:405-412.
4. Bhattacharya S., Manna P., Gachhui R., Sil P.C. d-Saccharic acid 1,4-lactone ameliorates alloxan-induced diabetes mellitus and oxidative stress in rats through inhibiting pancreatic b-cells from apoptosis via mitochondrial dependent pathway. Toxicol. Appl. Pharmacol. 2011, 257:272-283.
5. Bonaventura J., Schroeder W.A., Fang S. Human erythrocyte catalase: an improved method of isolation and a revaluation of reported properties. Arch. Biochem. Biophys. 1972, 150:606-617.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
8. Cain K., Bratton S.B., Cohen G.M. The Apaf-1 apoptosome: a large caspase activating complex. Biochimie 2002, 84:203-214.
9. Carneiroa E.M., Latorracab M.Q., Araujoc E., Beltrad M., Oliverase M.J., Navarro M., Berna G., Bedoya F.J., Vellosoc L.A., Soria B., Martin F. Taurine supplementation modulates glucose homeostasis and islet function. J. Nutr. Biochem. 2009, 20:503-511.
10. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000, 49:27-29.
11. Chang K.J., Kwon W. Immunohistochemical localization of insulin in pancreatic beta-cells of taurine-supplemented or taurine-depleted diabetic rats. Adv. Exp. Med. Biol. 2000, 483:579-587.
12. Chaudhry J., Ghosh N.N., Roy K., Chandra R. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. Life Sci. 2007, 80:1135-1142.
13. Cherif H., Reusens B., Ahn M.T., Hoet J.J., Remacle C. Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J. Endocrinol. 1998, 159:341-348.
14. Chinenye S., Uloko A.E., Ogbera A.O., Ofoegbu E.N., Fasanmade O.A., Fasanmade A.A., Ogbu O.O. Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): results of a multicenter study. Ind. J. Endocrinol. Metab. 2012, 16:558-564.
15. Cho S.Y., Park J.Y., Park E.M., Choi M.S., Lee M.K., Jeon S.M., Jang M.K., Kim M.J., Park Y.B. Alteration of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract. Clin. Chim. Acta 2002, 317:109-117.
16. Chuhwak E.K., Pam S.D. Diabetes co-existing with chronic liver disease: clinical features and response to therapy. Niger J. Med. 2007, 16:156-160.
17. Colivicchi M.A., Raimondi L., Bianchi L., Tipton K.F., Pirisino R., Della Corte L. Taurine prevents streptozotocin impairment of hormone-stimulated glucose uptake in rat a dipocytes. Eur. J. Pharmacol. 2004, 495:209-215.
18. Das J., Ghosh J., Manna P.M., Sil P.C. Taurine provides antioxidant defense against NaF-induced cytotoxicity in murine hepatocytes. Pathophysiology 2008, 15:181-190.
19. Das J., Ghosh J., Manna P., Sinha M., Sil P.C. Taurine protects rat testes against NaAsO2-induced oxidative stress and apoptosis via mitochondrial dependent and independent pathways. Toxicol. Lett. 2009, 187:201-210.
20. Das J., Ghosh J., Manna P., Sinha M., Sil P.C. Arsenic-induced oxidative cerebral disorders: protection by taurine. Drug Chem. Toxicol. 2009, 32:93-102.
21. Das J., Ghosh J., Manna P., Sil P.C. Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation. Toxicology 2010, 269:24-34.
22. Das J., Ghosh J., Manna P., Sil P.C. Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1. Free Radic. Res. 2010, 44:340-355.
23. Das J., Ghosh J., Manna P., Sil P.C. Protective role of taurine against arsenic induced mitochondria-dependent hepatic apoptosis via the inhibition of PKC delta-JNK pathway. PLoS ONE 2010, 5:e12602.
24. Das J., Ghosh J., Manna P., Sil P.C. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochem. Pharmacol. 2011, 81:891-909.
25. Das J., Ghosh J., Manna P., Sil P.C. Taurine protects rat testes against doxorubicin induced oxidative stress as well as p53, Fas and caspase12-mediated apoptosis. Amino Acids 2011, 42:1839-1855.
26. Das J., Vasan V., Sil P.C. Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signalling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. Toxicol. Appl. Pharmacol. 2012, 258:296-308.
27. Das J., Sil P.C. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids 2012, 43:1509-1523.
28. Di Leo M.A., Santini S.A., Silveri N.G., Giardina B., Franconi F., Ghirlanda G. Long-term taurine supplementation reduces mortality rate in streptozotocin induced diabetic rats. Amino Acids 2004, 27:187-191.
29. Du Y., Villeneuve N.F., Wang X.J., Sun Z., Chen W., Li J., Lou H., Wong P.K., Zhang D.D. Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ. Health Perspect. 2008, 116:1154-1161.
30. Eizirik D.L., Darville M.I. Beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes 2001, 50:S64-S69.
31. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990, 186:407-421.
32. Flohe L., Gunzler W.A. Assay of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
33. Fridovich I. Superoxide radical and superoxide dismutase. Acc. Chem. Res. 1972, 5:321-326.
34. Gavrovskaya L.K., Ryzhova O.V., Safonova A.F., Matveev A.K., Sapronov N.S. Protective effect of taurine on rats with experimental insulin-dependent diabetes mellitus. Bull. Exp. Biol. Med. 2008, 146:226-228.
35. Ghosh J., Das J., Manna P., Sil P.C. Taurine prevents arsenicinduced cardiac oxidative stress and apoptotic damage: role of NF-kappaB, p38 and JNK MAPK pathway. Toxicol. Appl. Pharmacol. 2009, 240:73-87.
36. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999, 13:1899-1911.
37. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
38. Hashemi M., Dostar Y., Rohani S.R., AziziSaraji A.R., Bayat M. Influence of aloxanes on the apoptosis of Pancreas B-cells of rat. World J. Med. Sci. 2009, 4:70-73.
39. Harrison S.A. Liver disease in patients with diabetes mellitus. J. Clin. Gastroenterol. 2006, 40:68-76.
40. Hissin P.J., Hilf R.A. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
41. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J. Gastroen. Hepatol. 2000, 15:718-724.
42. Jang Y.M., Kendaiah S., Drew B., Phillips T., Selman C., Julian D., Leeuwenburgh C. Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett. 2004, 577:483-490.
43. Jones P., Suggett A. The catalase-hydrogen peroxide system. a theoretical appraisal of the mechanism of catalase action. Biochem. J. 1968, 110:621-625.
44. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Ind. J. Biochem. Biophys. 1984, 21:130-132.
45. Kaplan B., Karabay G., Zagyapan R.D., Ozer C., Sayan H., Duyar I. Effect of taurine in glucose and taurine administration. Amino Acids 2004, 27:327-333.
46. Kayal R., Cakatay U., Telci A., Akçay T., Sivas A., Altǔg T. Decrease in mitochondrial oxidative protein damage parameters in the streptozotocin-diabetic rat. Diabetes Metab. Res. Rev. 2004, 20:315-321.
47. Ketterer B. Detoxification reactions of glutathione and glutathione reductase. Xenobiotica 1986, 16:957-975.
48. Kim J.O., Lee G.D., Kwon J.H., Kim K.S. Anti-diabetic effects of new herbal formula in neonatally streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 2009, 32:421-426.
49. Kim J.S., Ju J.B., Choi C.W., Kim S.C. Comparison between ethanolic and aqueous extracts from Chinese juniper berries for hypoglycaemic and hypolipidemic effects in alloxan-induced diabetic rats. J. Ethnopharmacol. 2008, 115:110-115.
50. Kim J.Y., Lee S.H., Song E.H., Park Y.M., Lim J.Y., Kim D.J., Choi K.H., Park S.I., Gao B., Kim W.H. A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice. Controlled by ATF3. Cell. Signal. 2009, 21:1758-1767.
51. König M., Bulik S., Holzhütter H.G. Quantifying the contribution of the liver to glucose homeostasis: a detailed kineticmodel of human hepatic glucose metabolism. PLoS Comput. Biol. 2012, 8(6):e1002577.
52. Kontny E., Szczepanska K., Kowalczewski J., Kurowska M., Janicka I., Marcinkiewicz J., et al. The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum. 2000, 43:2169-2177.
53. Kornberg Lactic dehydrogenase of muscle. Methods Enzymol. 1955, 1:441-443.
54. Kuo W.Y., Tang T.K. Effect of G6PD over expression in NIH3T3 cells 607 treated with tertbutyl hydroperoxide or paraquat. Free Radic. Biol. Med. 1998, 24:1130-1138.
55. Li F., Obrosova I.G., Abatan O., Tian D., Larkin D., Stuenkel E.L., Stevens M.J. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E29-E36.
56. Mandrup-Poulsen T. Apoptotic signal transduction pathways in diabetes. Biochem. Pharmacol. 2003, 66:1433-1440.
57. Manna P., Sinha M., Sil P.C. Amelioration of cadmium-induced cardiac impairment by taurine. Chem. Biol. Interact. 2008, 174:88-97.
58. Manna P., Sinha M., Sil P.C. Taurine triggers a chemoprevention against cadmium induced testicular oxidative injury. Reprod. Toxicol. 2008, 26:282-291.
59. Manna P., Sinha M., Sil P.C. Taurine plays a beneficial role against cadmium-induced oxidative renal dysfunction. Amino Acids 2009, 36:417-428.
60. Manna P., Ghosh J., Das J., Sil P.C. Streptozotocin induced activation of oxidative stress responsive splenic cell signaling pathways: protective role of arjunolic acid. Toxicol. Appl. Pharmacol. 2010, 244:114-129.
61. Manna P., Das J., Ghosh J., Sil P.C. Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NFkappaB, MAPKs, and mitochondria-dependent pathways: prophylactic role of arjunolic acid. Free Radic. Biol. Med. 2010, 48:1465-1484.
62. Menon V.P., Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 2007, 595:105-125.
63. Nishikimi M., Rao N.A., Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 1972, 46:849-854.
64. Michael M.D., Kulkarni R.N., Postic C., et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 2000, 6:87-97.
65. Olas B., Saluk-Juszcak J., Nowak P., Glowacki R., Bald E., Wachowicz B. Protective effects of d-glucaro 1,4-lactone against oxidative/nitrative modifications of plasma proteins. Nutrition 2007, 23:164-171.
66. Obrosova I.G., Minchenko A.G., Marinescu V., Fathallah L., Kennedy A., Stockert C.M., Frank R.N., Stevens M.J. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 2001, 44:1102-1110.
67. Pompella A., Visvikis A., Paolicchi A., De Tata V., Casini A.F. The changing faces of glutathione, a cellular protagonist. Biochem. Pharmacol. 2003, 66:1499-1503.
68. Racasan S., Braam B., van der Giezen D.M., Goldschmeding R., Boer P., Koomans H.A. Perinatal l-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension 2004, 44:83-88.
69. Rashid K., Bhattacharya S., Sil P.C. Protective role of d-saccharic acid-1,4-lactone in alloxan induced oxidative stress in the spleen tissue of diabetic rats is mediated by suppressing mitochondria dependent apoptotic pathway. Free Radic. Res. 2012, 46:240-252.
70. Rotem R., Heyfets A., Fingrut O., Blickstein D., Shaklai M., Flescher E. Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res. 2005, 65:1984-1993.
71. Rovetta F., Stacchiotti A., Consiglio A., Cadei M., Grigolato P.G., Lavazza A., Rezzani R., Aleo M.F. ER signaling regulation drives the switch between autophagy and apoptosis in NRK-52E cells exposed to cisplatin. Exp. Cell Res. 2012, 318:238-250.
72. Roy A., Manna P., Sil P.C. Prophylactic role of taurine on arsenic mediated oxidative renal dysfunction via MAPKs/NFkappaB and mitochondria dependent pathways. Free Radic. Res. 2009, 43:995-1007.
73. Roy A., Sil P.C. Taurine protects murine hepatocytes against oxidative stress-induced apoptosis by tert-butyl hydroperoxide via PI3K/Akt and mitochondrial dependent pathways. Food Chem. 2012, 131:1086-1096.
74. Sambrook J., Fritsch F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, CSHL press, NY.
75. Seven A., Guzel S., Seymen O., Civelek S., Bolayirh M., Uncu M., Burcak G. Effect of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma. Yonsei Med. J. 2004, 45:703-710.
76. Shanmugam K.R., Mallikarjuna K., Reddy K.S. Effect of alcohol on blood glucose and antioxidant enzymes in the liver and kidney of diabetic rats. Ind. J. Pharmacol. 2011, 43:330-335.
77. Singh N., Anand S. Cell death by apoptosis. Ind. J. Exp. Biol. 1994, 32:843-847.
78. Sinha M., Manna P., Sil P.C. Taurine, a conditionally essential amino acid, ameliorates arsenic-induced cytotoxicity in murine hepatocytes. Toxicol. In Vitro 2007, 21:1419-1425.
79. Sinha M., Manna P., Sil P.C. Taurine protects antioxidant defense system in the erythrocytes of cadmium treated mice. BMB Rep. 2008, 41:657-663.
80. Sinha M., Manna P., Sil P.C. Cadmium induced neurological disorders: prophylactic role of taurine. J. Appl. Toxicol. 2008, 28:974-986.
81. Sinha M., Manna P., Sil P.C. Induction of necrosis in cadmiuminduced hepatic oxidative stress and its prevention by the prophylactic properties of taurine. J. Trace Elem. Med. Biol. 2009, 23:300-313.
82. Smith I.K., Vierheller T.L., Thorne C.A. Assay of glutathione reductase in crude tissue homogenates using 5,5'-dithiobis (2-nitrobenzoic acid). Anal. Biochem. 1988, 175:408-413.
83. Stadler K., Jenei V., Bolcshazy G., Somogyi A., Jakus J. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic. Biol. Med. 2003, 35:1240-1251.
84. Szkudelski T. The mechanism of alloxan and streptozotocin action in B-cells of the rat pancreas. Physiol. Res. 2001, 50:537-546.
85. Taniguchi C.M., Ueki K., Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest. 2005, 115:718-727.
86. Tokunaga H., Yoneda Y., Kuriyama K. Streptozotocin-induced elevation of pancreatic taurine content and suppressive effect of taurine on insulin secretion. Eur. J. Pharmacol. 1983, 87:237-243.
87. Uchida K., Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J. Biol. Chem. 1993, 268:6388-6393.
88. Vasqueza N.A., Zamudioa P., Cerona E., Vandab B., Zentenoc E., Sandovala G.C. Effect of glycine in streptozotocin-induced diabetic rats. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2003, 134:521-527.
89. Verma L., Singour P.K., Chaurasiya P.K., Rajak H., Pawar R.S., Patil U.K. Effect of ethanolic extract of Cassia occidentalis Linn. for the management of alloxan induced diabetic rats. Pharmacognosy Res. 2010, 2:132-137.
90. Winiarska K., Szymanski K., Gorniak P., Dudziak M., Bryla J. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie 2009, 91:261-270.
91. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem. J. 1987, 245:243-250.
92. Wu N., Lu Y., He B., Zhang Y., Lin J., Zhao S., Zhang W., Li Y., Han P. Taurine prevents free fatty acid-induced hepatic insulin resistance in association with inhibiting JNK1 activation and improving insulin signaling in vivo. Diab. Res. Clin. Pract. 2010, 90:288-296.
93. Yao H.T., Lin P.P., Chang Y.W., Chen C.T., Chiang M.T., Chang L., Kuo Y.C., Tsai H.T., Yeh T.K. Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocin-induced diabetes. Food Chem. Toxicol. 2009, 47:1703-1709.
94. Yim S., Malhotra A., Veves A. Antioxidants and CVD in diabetes: where do we stand now?. Curr. Diab. Rep. 2007, 7:8-13.
95. Zhang X., Chen L.X., Ouyang L., Cheng Y., Liu B. Plant natural compounds: targeting pathways of autophagy asanti-cancer therapeutic agents. Cell Prolif. 2012, 45:466-476.